Education
About Us
Working with TipRanks
Follow Us
Avanos Medical, Inc. (AVNS)
:AVNS
AVNS Stock Chart & Stats
$11.76
-$0.16(-1.03%)
At close: 4:00 PM EST
$11.76
-$0.16(-1.03%)
Day’s Range― - ―
52-Week Range$9.30 - $21.12
Previous CloseN/A
Volume92.13K
Average Volume (3M)482.47K
Market Cap
$524.35M
Enterprise ValueN/A
Total Cash (Recent Filing)$70.50M
Total Debt (Recent Filing)$133.70M
Price to Earnings (P/E)―
Beta1.02
Next Earnings
Feb 24, 2026EPS Estimate
0.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.22
Shares Outstanding46,402,480
10 Day Avg. Volume435,596
30 Day Avg. Volume482,466
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.88
Price to Sales (P/S)1.06
P/FCF Ratio8.83
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Business DevelopmentsAVNS recorded some positive developments during the quarter, which include completing the divestiture of its respiratory health business, exceeding internal expectations on its Trident U.S. market launch, as well as improving its capital position.
Financial PerformanceAvanos Medical posted a moderate quarterly beat on both the top and bottom lines, with a strong quarter from its Digestive Health business.
Bears Say
Guidance And Market ConditionsManagement's initial full-year 2025 guidance was light of Street expectations, calling for flat to slight declines in both revenue and earnings, reflecting a challenging market environment for some of its product categories, currency headwinds, and other macro factors.
Pricing PressuresThe hyaluronic acid injection business continues to be a sore spot with ongoing pricing pressures highlighted as a key factor underpinning the company’s below-Consensus initial 2025 guidance.
Avanos Medical News
AVNS FAQ
What was Avanos Medical, Inc.’s price range in the past 12 months?
Avanos Medical, Inc. lowest stock price was $9.30 and its highest was $21.12 in the past 12 months.
What is Avanos Medical, Inc.’s market cap?
Avanos Medical, Inc.’s market cap is $524.35M.
When is Avanos Medical, Inc.’s upcoming earnings report date?
Avanos Medical, Inc.’s upcoming earnings report date is Feb 24, 2026 which is in 110 days.
How were Avanos Medical, Inc.’s earnings last quarter?
Avanos Medical, Inc. released its earnings results on Nov 05, 2025. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.12 by $0.1.
Is Avanos Medical, Inc. overvalued?
According to Wall Street analysts Avanos Medical, Inc.’s price is currently Overvalued.
Does Avanos Medical, Inc. pay dividends?
Avanos Medical, Inc. does not currently pay dividends.
What is Avanos Medical, Inc.’s EPS estimate?
Avanos Medical, Inc.’s EPS estimate is 0.25.
How many shares outstanding does Avanos Medical, Inc. have?
Avanos Medical, Inc. has 46,402,480 shares outstanding.
What happened to Avanos Medical, Inc.’s price movement after its last earnings report?
Avanos Medical, Inc. reported an EPS of $0.22 in its last earnings report, beating expectations of $0.12. Following the earnings report the stock price went down -5.664%.
Which hedge fund is a major shareholder of Avanos Medical, Inc.?
Currently, no hedge funds are holding shares in AVNS
Avanos Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AVNS Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 148.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $659.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-46.10%
12-Months-Change
Fundamentals
Return on Equity
-46.17%
Trailing 12-Months
Asset Growth
-37.33%
Trailing 12-Months
Company Description
Avanos Medical, Inc.
Avanos Medical, Inc. is a global medical technology company that specializes in developing and manufacturing innovative products focused on pain management and surgical solutions. The company operates primarily in two main sectors: Surgical and Pain Management. Avanos offers a range of core products, including catheters, wound care devices, and specialized surgical instruments, designed to improve patient outcomes and enhance the efficiency of healthcare providers.
AVNS Company Deck
AVNS Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong performance in the Specialty Nutrition Systems segment and successful strategic moves, such as the acquisition of Nexus Medical. However, challenges with tariffs, flat growth in certain segments, and increased capital expenditures were notable concerns.View all AVNS earnings summariesTechnical Analysis
Ownership Overview
2.51% Insiders
27.88% Mutual Funds
0.11% Other Institutional Investors
44.56% Public Companies and
Individual Investors